Report Detail
Global Infectious Disease In Vitro Diagnostics Market Growth (Status and Outlook) 2022-2028
- RnM4497957 |
- 08 December, 2022 |
- Global |
- 102 Pages |
- LPI(LP Information) |
- Medical Industry
The global industry is witnessing growth due to the factors, such as the growing geriatric population susceptible to infectious diseases, high demand for PoC testing owing to the pandemic, rising awareness about early testing, and rising prevalence of infectious diseases.
The global market for Infectious Disease In Vitro Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Infectious Disease In Vitro Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Infectious Disease In Vitro Diagnostics players cover QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd. and Hologic, Inc. (Gen-Probe), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Infectious Disease In Vitro Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Infectious Disease In Vitro Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Infectious Disease In Vitro Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Infectious Disease In Vitro Diagnostics market and forecasts the market size by Type (Instruments and Reagents,), by Application (Hospitals & Clinics, Diagnostic Laboratories and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Instruments
Reagents
Segmentation by application
Hospitals & Clinics
Diagnostic Laboratories
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
QIAGEN
BD
bioMérieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.
Siemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc.
Chapter Introduction
Chapter 1: Scope of Infectious Disease In Vitro Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Infectious Disease In Vitro Diagnostics market size and CAGR, Infectious Disease In Vitro Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Infectious Disease In Vitro Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Infectious Disease In Vitro Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Infectious Disease In Vitro Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG and Bio-Rad Laboratories, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Infectious Disease In Vitro Diagnostics Market Size 2017-2028
- 2.1.2 Infectious Disease In Vitro Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Infectious Disease In Vitro Diagnostics Segment by Type
- 2.2.1 Instruments
- 2.2.2 Reagents
- 2.3 Infectious Disease In Vitro Diagnostics Market Size by Type
- 2.3.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Type (2017-2022)
- 2.4 Infectious Disease In Vitro Diagnostics Segment by Application
- 2.4.1 Hospitals & Clinics
- 2.4.2 Diagnostic Laboratories
- 2.4.3 Others
- 2.5 Infectious Disease In Vitro Diagnostics Market Size by Application
- 2.5.1 Infectious Disease In Vitro Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Infectious Disease In Vitro Diagnostics Market Size Market Share by Application (2017-2022)
3 Infectious Disease In Vitro Diagnostics Market Size by Player
- 3.1 Infectious Disease In Vitro Diagnostics Market Size Market Share by Players
- 3.1.1 Global Infectious Disease In Vitro Diagnostics Revenue by Players (2020-2022)
- 3.1.2 Global Infectious Disease In Vitro Diagnostics Revenue Market Share by Players (2020-2022)
- 3.2 Global Infectious Disease In Vitro Diagnostics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease In Vitro Diagnostics by Regions
- 4.1 Infectious Disease In Vitro Diagnostics Market Size by Regions (2017-2022)
- 4.2 Americas Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
- 4.3 APAC Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
- 4.4 Europe Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Infectious Disease In Vitro Diagnostics Market Size by Country (2017-2022)
- 5.2 Americas Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
- 5.3 Americas Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Infectious Disease In Vitro Diagnostics Market Size by Region (2017-2022)
- 6.2 APAC Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
- 6.3 APAC Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Infectious Disease In Vitro Diagnostics by Country (2017-2022)
- 7.2 Europe Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
- 7.3 Europe Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Infectious Disease In Vitro Diagnostics by Region (2017-2022)
- 8.2 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Infectious Disease In Vitro Diagnostics Market Forecast
- 10.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
- 10.1.1 Global Infectious Disease In Vitro Diagnostics Forecast by Regions (2023-2028)
- 10.1.2 Americas Infectious Disease In Vitro Diagnostics Forecast
- 10.1.3 APAC Infectious Disease In Vitro Diagnostics Forecast
- 10.1.4 Europe Infectious Disease In Vitro Diagnostics Forecast
- 10.1.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast
- 10.2 Americas Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
- 10.2.1 United States Infectious Disease In Vitro Diagnostics Market Forecast
- 10.2.2 Canada Infectious Disease In Vitro Diagnostics Market Forecast
- 10.2.3 Mexico Infectious Disease In Vitro Diagnostics Market Forecast
- 10.2.4 Brazil Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3 APAC Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
- 10.3.1 China Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3.2 Japan Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3.3 Korea Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3.4 Southeast Asia Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3.5 India Infectious Disease In Vitro Diagnostics Market Forecast
- 10.3.6 Australia Infectious Disease In Vitro Diagnostics Market Forecast
- 10.4 Europe Infectious Disease In Vitro Diagnostics Forecast by Country (2023-2028)
- 10.4.1 Germany Infectious Disease In Vitro Diagnostics Market Forecast
- 10.4.2 France Infectious Disease In Vitro Diagnostics Market Forecast
- 10.4.3 UK Infectious Disease In Vitro Diagnostics Market Forecast
- 10.4.4 Italy Infectious Disease In Vitro Diagnostics Market Forecast
- 10.4.5 Russia Infectious Disease In Vitro Diagnostics Market Forecast
- 10.5 Middle East & Africa Infectious Disease In Vitro Diagnostics Forecast by Region (2023-2028)
- 10.5.1 Egypt Infectious Disease In Vitro Diagnostics Market Forecast
- 10.5.2 South Africa Infectious Disease In Vitro Diagnostics Market Forecast
- 10.5.3 Israel Infectious Disease In Vitro Diagnostics Market Forecast
- 10.5.4 Turkey Infectious Disease In Vitro Diagnostics Market Forecast
- 10.5.5 GCC Countries Infectious Disease In Vitro Diagnostics Market Forecast
- 10.6 Global Infectious Disease In Vitro Diagnostics Forecast by Type (2023-2028)
- 10.7 Global Infectious Disease In Vitro Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 QIAGEN
- 11.1.1 QIAGEN Company Information
- 11.1.2 QIAGEN Infectious Disease In Vitro Diagnostics Product Offered
- 11.1.3 QIAGEN Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 QIAGEN Main Business Overview
- 11.1.5 QIAGEN Latest Developments
- 11.2 BD
- 11.2.1 BD Company Information
- 11.2.2 BD Infectious Disease In Vitro Diagnostics Product Offered
- 11.2.3 BD Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 BD Main Business Overview
- 11.2.5 BD Latest Developments
- 11.3 bioMérieux SA
- 11.3.1 bioMérieux SA Company Information
- 11.3.2 bioMérieux SA Infectious Disease In Vitro Diagnostics Product Offered
- 11.3.3 bioMérieux SA Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 bioMérieux SA Main Business Overview
- 11.3.5 bioMérieux SA Latest Developments
- 11.4 F. Hoffmann-La Roche, Ltd.
- 11.4.1 F. Hoffmann-La Roche, Ltd. Company Information
- 11.4.2 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Product Offered
- 11.4.3 F. Hoffmann-La Roche, Ltd. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
- 11.4.5 F. Hoffmann-La Roche, Ltd. Latest Developments
- 11.5 Hologic, Inc. (Gen-Probe)
- 11.5.1 Hologic, Inc. (Gen-Probe) Company Information
- 11.5.2 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Product Offered
- 11.5.3 Hologic, Inc. (Gen-Probe) Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Hologic, Inc. (Gen-Probe) Main Business Overview
- 11.5.5 Hologic, Inc. (Gen-Probe) Latest Developments
- 11.6 Abbott
- 11.6.1 Abbott Company Information
- 11.6.2 Abbott Infectious Disease In Vitro Diagnostics Product Offered
- 11.6.3 Abbott Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Abbott Main Business Overview
- 11.6.5 Abbott Latest Developments
- 11.7 Quidel Corp.
- 11.7.1 Quidel Corp. Company Information
- 11.7.2 Quidel Corp. Infectious Disease In Vitro Diagnostics Product Offered
- 11.7.3 Quidel Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Quidel Corp. Main Business Overview
- 11.7.5 Quidel Corp. Latest Developments
- 11.8 Siemens Healthineers AG
- 11.8.1 Siemens Healthineers AG Company Information
- 11.8.2 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Product Offered
- 11.8.3 Siemens Healthineers AG Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Siemens Healthineers AG Main Business Overview
- 11.8.5 Siemens Healthineers AG Latest Developments
- 11.9 Bio-Rad Laboratories, Inc.
- 11.9.1 Bio-Rad Laboratories, Inc. Company Information
- 11.9.2 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Product Offered
- 11.9.3 Bio-Rad Laboratories, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
- 11.9.5 Bio-Rad Laboratories, Inc. Latest Developments
- 11.10 Danaher Corp.
- 11.10.1 Danaher Corp. Company Information
- 11.10.2 Danaher Corp. Infectious Disease In Vitro Diagnostics Product Offered
- 11.10.3 Danaher Corp. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Danaher Corp. Main Business Overview
- 11.10.5 Danaher Corp. Latest Developments
- 11.11 OraSure Technologies, Inc.
- 11.11.1 OraSure Technologies, Inc. Company Information
- 11.11.2 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Product Offered
- 11.11.3 OraSure Technologies, Inc. Infectious Disease In Vitro Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 OraSure Technologies, Inc. Main Business Overview
- 11.11.5 OraSure Technologies, Inc. Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Infectious Disease In Vitro Diagnostics. Industry analysis & Market Report on Infectious Disease In Vitro Diagnostics is a syndicated market report, published as Global Infectious Disease In Vitro Diagnostics Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Infectious Disease In Vitro Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
